MARKET

ABT

ABT

Abbott
NYSE

Real-time Quotes | Nasdaq Last Sale

124.37
-0.93
-0.74%
After Hours: 124.38 +0.01 +0.01% 19:55 09/24 EDT
OPEN
124.81
PREV CLOSE
125.30
HIGH
125.48
LOW
124.27
VOLUME
3.05M
TURNOVER
--
52 WEEK HIGH
129.70
52 WEEK LOW
100.34
MARKET CAP
220.49B
P/E (TTM)
34.81
1D
5D
1M
3M
1Y
5Y
Semiconductor Shortage Hits Supply Chain For MedTech Industry
Benzinga · 22h ago
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests.
Benzinga · 22h ago
Breast Cancer Screening Market Industry Analysis, Size, Share, Growth, Trends and Forecast 2027 | Impact of COVID-19 Pandemic
Breast Cancer among women is anticipated to be the leading growth factor for the market in the upcoming years. However, the exposure to radiation and intake of chemicals such as Barium might lead to the development of various health issues, which is antici...
AmericaNewsHour · 1d ago
Antiretroviral Drugs Market: Industry Insights By Growth, Emerging Trends And Forecast By 2028
Research Nester has published a report titled "which delivers detailed overview of the antiretroviral drugs market in terms of market segmentation by drug type and by region.
AmericaNewsHour · 1d ago
COVID-19 test maker Cue Health prices 12.5M-share IPO at $16
Cue Health (NASDAQ:HLTH) has priced its IPO of 12.5M shares of common stock at $16.00/share, for gross proceeds of $200M at a target valuation of around $2.4B. Nasdaq trading commences on September
Seekingalpha · 1d ago
Top Stocks To Buy Today? 4 Health Care Stocks For Your Watchlist
StockMarket.com · 1d ago
Abbott Labs Wins $2.1M Navy Contract For 'Chemistry Analyzer-Bremerton'
https://sam.gov/opp/4fc7a3dc109e45ebb048a3dbf450b665/view
Benzinga · 1d ago
3 Promising MedTech Stocks to Snap Up in Second-Half 2021
Zacks.com · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABT. Analyze the recent business situations of Abbott through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 25 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABT stock price target is 132.05 with a high estimate of 158.00 and a low estimate of 109.00.
EPS
Institutional Holdings
Institutions: 3.02K
Institutional Holdings: 1.40B
% Owned: 79.05%
Shares Outstanding: 1.77B
TypeInstitutionsShares
Increased
1.02K
49.35M
New
116
6.02M
Decreased
922
57.55M
Sold Out
118
5.60M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/Executive Director
Miles White
President/Chief Executive Officer/Director
Robert Ford
Chief Financial Officer/Executive Vice President - Finance
Robert Funck
Executive Vice President/General Counsel/Secretary
Hubert Allen
Executive Vice President/Director of Human Resources
Mary Moreland
Executive Vice President
John Capek
Executive Vice President
Lisa Earnhardt
Executive Vice President
John Ginascol
Executive Vice President
Andrew Lane
Executive Vice President
Daniel Salvadori
Executive Vice President
Andrea Wainer
Senior Vice President
Gregory Ahlberg
Senior Vice President
Roger Bird
Senior Vice President
Charles Brynelsen
Senior Vice President
Michael Dale
Senior Vice President
Sammy Karam
Senior Vice President
Joseph Manning
Senior Vice President
Michael Pederson
Senior Vice President
Christopher Scoggins
Senior Vice President
Jared Watkin
Senior Vice President
Alejandro Wellisch
Senior Vice President
Randel Woodgrift
Vice President - Finance/Controller
Philip Boudreau
Lead Director/Independent Director
William Osborn
Director
Patricia Gonzalez
Independent Director
Robert Alpern
Independent Director
Roxanne Austin
Independent Director
Sally Blount
Independent Director
Michelle Kumbier
Independent Director
Darren McDew
Independent Director
Nancy Mckinstry
Independent Director
Daniel Starks
Independent Director
John Stratton
Independent Director
Glenn Tilton
Declaration Date
Dividend Per Share
Ex-Div Date
06/11/2021
Dividend USD 0.45
07/14/2021
02/19/2021
Dividend USD 0.45
04/14/2021
12/11/2020
Dividend USD 0.45
01/14/2021
09/17/2020
Dividend USD 0.36
10/14/2020
06/12/2020
Dividend USD 0.36
07/14/2020
02/21/2020
Dividend USD 0.36
04/14/2020
12/13/2019
Dividend USD 0.36
01/14/2020
09/12/2019
Dividend USD 0.32
10/11/2019
06/14/2019
Dividend USD 0.32
07/12/2019
02/22/2019
Dividend USD 0.32
04/12/2019
12/14/2018
Dividend USD 0.32
01/14/2019
09/13/2018
Dividend USD 0.28
10/12/2018
06/08/2018
Dividend USD 0.28
07/12/2018
02/16/2018
Dividend USD 0.28
04/12/2018
12/15/2017
Dividend USD 0.28
01/11/2018
09/14/2017
Dividend USD 0.265
10/12/2017
06/09/2017
Dividend USD 0.265
07/12/2017
02/21/2017
Dividend USD 0.265
04/11/2017
12/12/2016
Dividend USD 0.265
01/11/2017
09/16/2016
Dividend USD 0.26
10/12/2016
  • All
  • Financials
  • Insiders
More
About ABT
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.

Webull offers kinds of Abbott Laboratories stock information, including NYSE:ABT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABT stock methods without spending real money on the virtual paper trading platform.